Compare POOL & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POOL | RGEN |
|---|---|---|
| Founded | 1993 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 8.2B |
| IPO Year | 1995 | N/A |
| Metric | POOL | RGEN |
|---|---|---|
| Price | $267.92 | $163.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $308.57 | $177.18 |
| AVG Volume (30 Days) | ★ 789.5K | 600.1K |
| Earning Date | 02-19-2026 | 02-19-2026 |
| Dividend Yield | ★ 1.87% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 10.93 | 0.03 |
| Revenue | ★ $5,294,666,000.00 | $707,890,000.00 |
| Revenue This Year | $1.92 | $17.86 |
| Revenue Next Year | $3.55 | $12.44 |
| P/E Ratio | ★ $24.53 | $5,247.54 |
| Revenue Growth | N/A | ★ 11.74 |
| 52 Week Low | $226.10 | $102.97 |
| 52 Week High | $374.74 | $182.52 |
| Indicator | POOL | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 75.59 | 48.28 |
| Support Level | $234.28 | $158.80 |
| Resistance Level | $268.72 | $172.51 |
| Average True Range (ATR) | 6.38 | 6.24 |
| MACD | 4.47 | -0.83 |
| Stochastic Oscillator | 98.30 | 25.84 |
Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.